Axonal loss and myelin in early on loss in postacute optic neuritis

Annals of Neurology

Volumn 64, Issue 3, 2008, Pages 325-331

  Klistorner, Alexander ^a,d   Arvind, Hemamalini ^a   Nguyen, Than ^b   Garrick, Raymond ^c   Paine, Mark ^b   Graham, Stuart ^a   O'Day, Justin ^b   Grigg, John ^a   Billson, Francis ^a   Yiannikas, Con ^c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d NONE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MYELIN;

ADULT; ARTICLE; CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; CONTROLLED STUDY; DEMYELINATION; EVOKED VISUAL RESPONSE; FEMALE; HUMAN; LATENT PERIOD; MALE; MULTIPLE SCLEROSIS; NERVE FIBER; NERVE FIBER DEGENERATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NERVE; OPTIC NEURITIS; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; RETINA NERVE CELL; THICKNESS;

ACUTE DISEASE; ADULT; AXONS; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; ELECTRODIAGNOSIS; EVOKED POTENTIALS, VISUAL; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYELIN SHEATH; NERVE DEGENERATION; NEURAL CONDUCTION; OPTIC NERVE; OPTIC NEURITIS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REACTION TIME; RETINA; RETINAL GANGLION CELLS; TIME FACTORS; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 54849423453     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.21474     Document Type: Article

References (44)

1. Lassmann H. Pathology of neurons in multiple sclerosis. In: Waxman SG, ed. Multiple sclerosis as a neuronal disease. Amsterdam: Elsevier, 2005:153-164.
2. Ferguson B, Matyszak MK, Esiri MM, Perry VH. Axonal damage in acute multiple sclerosis lesions. Brain 1997;120:393-399.
3. Trapp BD, Peterson J, Ransohoff RM, et al. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998;338:278-285.
4. Bjartmar C, Wujek J, Trapp B. Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease. J Neurol Sci 2003;206:165-171.
5. Trapp B, Ransohoff R, Rudick R. Axonal pathology in multiple sclerosis: relationship to neurologic disability. Curr Opin Neurol 1999;12:295-302.
6. Peterson LK, Fujinami RS. Inflammation, demyelination, neurodegeneration and neuroprotection in the pathogenesis of multiple sclerosis. J Neuroimunol 2007;184:37-44.
7. Filippi M, Rocca M. MRI evidence for multiple sclerosis as a diffuse disease of the central nervous system. J Neurol 2005;252(suppl):v16-v24.
8. DeLuca GC, Williams K, Evangelou N, et al. The contribution of demyelination to axonal loss in multiple sclerosis. Brain 2006;129:1507-1516.
9. Beck RW, Trobe JD, Moke PS, et al. High-and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: experience of the optic neuritis treatment trial. Arch Ophthalmol 2003;121:944-949.
10. Youl BD, Turano G, Miller DH, et al. The pathophysiology of acute optic neuritis. An association of gadolinium leakage with clinical and electrophysiological deficits. Brain 1991;114:2437-2450.
11. Trip A, Schlottmann PG, Jones SJ, et al. Optic nerve atrophy and retinal nerve fibre layer thinning following optic neuritis: evidence that axonal loss is a substrate of MRI-detected atrophy. Neuroimage 2006;31:286-293.
12. Kallenbach K, Fredericksen JL. Optical coherence tomography in optic neuritis and multiple sclerosis: a review. Eur J Neurol 2007;14:841-849.
13. Sergott RC, Frohman EM, Glanzman R, Al-Sabbagh A. Optical coherence tomography in multiple slerosis:expert panel consensus. J Neurol Sci 2007;263:3-14.
14. Nuver MR. Evoked potentials. In: Cook SD, ed. Handbook on multiple sclerosis. New York: Taylor & Francis, 2006:243-269.
15. Jones SJ, Brusa A. Neurophysiological evidence for long-term repair of MS lesions: implications for axon protection. J Neurol Sci 2003;206:193-198.
16. Halliday AM, McDonald WI, Mushin J. Delayed visual evoked response in optic neuritis. Lancet 1972;i:982-985.
17. Klistorner A, Graham SL, Fraser C, et al. Electrophysiological evidence for heterogeneity of lesions in optic neuritis. Invest Ophthalmol Vis Sci 2007;48:4549-4556.
18. Yiannikas C, Walsh JC. The variation of the pattern shift visual evoked response with the size of the stimulus field. Electroencephalogr Clin Neurophysiol 1983;55:427-435.
19. Klistorner AI, Graham SL, Grigg JR, Billson FA. Multifocal topographic visual evoked potential: improving objective detection of local visual field defects. Invest Ophthalmol Vis Sci 1998;39:937-950.
20. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of the multiple sclerosis. Ann Neurol 2001;50:121-127.
21. Klistorner A, Graham SL. Electroencephalogram-based scaling of multifocal visual evoked potentials: effect on intersubject amplitude variability. Invest Ophthalmol Vis Sci 2001;42:2145-2152.
22. Graham SL, Klistorner A. The diagnostic significance of the multifocal pattern visual evoked potential in glaucoma. Curr Opin Ophthalmol 1999;10:140-146.
23. Paunescu LA, Schuman JS, Price LL, et al. Variation of nerve fibre layer thickness measurements with age and ethnicity by scanning laser polarimetry. Invest Ophthalmol Vis Sci 2004;40:2520-2527.
24. Graham SL, Klistorner A, Grigg JR, Billson FA. Objective VEP perimetry in glaucoma - asymmetry analysis to identify early deficits. J Glaucoma 2000;9:10-19.
25. Graham SL, Klistorner AI, Grigg JR, Billson FA. Objective VEP perimetry in glaucoma: asymmetry analysis to identify early deficits. J Glaucoma 2000;9:10-19.
26. Parisi V, Manni G, Centofanti M, et al. Correlation between optical coherence tomography, pattern electroretinogram, and visual evoked potentials in open-angle glaucoma patients. Ophthalmology 2001;108:905-912.
27. Trip A, Schlottmann PG, Jones SJ, et al. Retinal nerve fiber layer loss and visual disfunction in optic neuritis. Ann Neurol 2005;58:383-391.
28. Costello F, Coupland S, Hodge W, et al. Quantifying axonal loss after optic neuritis with optical coherent tomography. Ann Neurol 2006;59:963-969.
29. Fisher JB, Jacobs DA, Markowitz CE, et al. Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis. Ophthalmology 2006;113:324-332.
30. Parisi V, Manni G, Spadaro M, et al. Correlation between morphological and functional retinal impairment in multiple sclerosis patients. Invest Ophthalmol Vis Sci 1999;40:2520-2527.
31. Noval S, Contreras I, Rebolleda G, Munoz-Negrete FJ. Optical coherence tomography versus automated perimetry for follow-up of optic neuritis. Acta Ophthalmol Scand 2006;84:790-794.
32. Beck RW, Kupersmith MJ, Cleary PA, Katz B. Fellow eye abnormalities in acute unilateral optic neuritis. Ophthalmology 1992;100:691-698.
33. Pulicken M, Gordon-Lipkin E, Balcer LJ, et al. Optical coherence tomography and disease subtype in multiple sclerosis. Neurology 2007;69:2085-2092.
34. Sergott RC, Frohman EM, Glanzman R, Al-Sabbagh A; OCT in MS Expert Panel. The role of optical coherence tomography in multiple sclerosis: expert panel consensus. J Neurol Sci 2007;263:3-14.
35. Costello F, Hodge W, Pan I, et al. Retinal nerve fibre layer loss after optic neuritis: a prospective study with optical coherence tomography. Presented at 23rd Congress of the European Committee for treatment and research in multiple sclerosis. October 11-14, 2007, Prague.
36. Brusa A, Jones SJ, Plant GT. Long-term remyelination after optic neuritis. Brain 2001;124:468-479.
37. Kornek B, Storch MK, Weissert R, et al. Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative study of axonal injury in active, inactive and remyelinated lesons. Am J Pathol 2000;157:267-276.
38. De Groot CJA, Ruuls SR, Theeuwes JMW, et al. Immunocytochemical characterization of the expression of inducible and constitutive isoforms of nitric oxide synthase in demyelinating multiple sclerosis lesions. J Neuropathol Exp Neurol 1997;56:10-20.
39. Peterson J, Kidd D, Trapp BD. Axonal degeneration in multiple sclerosis: the histopathological evidence. In: Waxman SG, ed. Multiple sclerosis as a neuronal disease. Amsterdam: Elsevier, 2005.
40. Smith KJ, Waxman SG. The conduction properties of demyelinated and remyelinated axonx. In: Waxman SG, ed. Multiple sclerosis as a neuronal disease. Amsterdam: Elsevier Academic Press, 2005.
41. Lassmann H. New concepts on progressive multiple sclerosis. Curr Neurol Neurosci Rep 2007;7:239-244.
42. Allen IV, McQuaid S, Mirakhur M, Nevin G. Pathological abnormalities in the normal-appearing white matter in multiple sclerosis. Neurol Sci 2001;22:141-144.
43. Fernando K, Tozer DJ, Miszkiel KA, et al. Magnetization transfer histograms in clinically isolated syndromes suggestive of multiple sclerosis. Brain 2005;128:2911-2925.
44. Pro MJ, Pons ME, Liebmann JM, et al. Imaging of the optic disk and retinal nerve fiber layer in acute optic neuritis. J Neurol Sci 2006;250:114-119.